Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Market Research Future | PRODUCT CODE: 1332099

Cover Image

PUBLISHER: Market Research Future | PRODUCT CODE: 1332099

Europe Anti-Acne Dermal Patch Market Research Report Forecast to 2030

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2950
PDF (Multi User License)
USD 3950
PDF (Enterprise License)
USD 5250

Add to Cart

Market Overview

The growth of the Europe anti-acne dermal patch market is attributed to the rising prevalence of acne vulgaris across Europe, increasing sedentary lifestyles and unhealthy food habits, and the high influence of social media and brand endorsements. However, the concerns pertaining to rashes and allergies might hamper the market's growth in the forecast period. Nevertheless, it is anticipated that the growing adoption of chemical-free products among consumers will create lucrative opportunities for the players operating in the European anti-acne dermal patch market.

The Europe anti-acne dermal patch market is emerging due to the rising prevalence of acne vulgaris across Europe, increasing sedentary lifestyles and unhealthy food habits, and the high influence of social media and brand endorsements. Additionally, the growing adoption of chemical-free products among consumers will provide growth opportunities for the market in the future. However, the concerns pertaining to rashes and allergies might hamper the market's growth in the forecast period.

Market Segmentation

Based on acne type, the Europe anti-acne dermal patch market has been segmented into inflammatory and non-inflammatory acne.

Based on patch type, the Europe anti-acne dermal patch market has been segmented into medicated, non-medicated, and micro-needle. Medicated further segmented into hydrocolloid based, salicylic acid-based, and hyaluronic acid-based.

Based on ingredient type, the Europe anti-acne dermal patch market has been segmented into chemical based and herbal-based. Based on the distribution channel, the Europe anti-acne dermal patch market has been segmented into retail stores, pharmacies & drug stores, and e-commerce platforms.

The Europe region is comprised of countries including Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Europe region is driven by several factors, including high consumption of cigarette smoke among men, an increasing prevalence of acne vulgaris among women, and an increasing prevalence of comorbid diseases such as polycystic ovary syndrome, diabetes, and obesity among women. Germany country dominated the market in 2021 and France is projected to be the fastest-growing during the forecast period, 2022-2030.

Major Players

3M (US), Church & Dwight Co Inc (US), EcoFeminii Ltd (US), Avalon Natural Products, Inc (US), ZitSticka (US), Mario Badescu Skin Care Inc (US), Starface (US), Peace Out LLC (US), COSRX (South Korea), and Peach & Lilly (US) are key players in the market.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 RISING PREVALENCE OF ACNE VULGARIS ACROSS EUROPE
    • 4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS
    • 4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS
  • 4.3 RESTRAINTS
    • 4.3.1 CONCERNS PERTAINING TO RASHES AND ALLERGIES
  • 4.4 OPPORTUNITY
    • 4.4.1 GROWING ADOPTION OF CHEMICAL-FREE PRODUCTS AMONG CONSUMERS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 MARKETING AND DISTRIBUTION
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE EUROPE ANTI-ACNE DERMAL PATCH MARKET

6 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE

  • 6.1 OVERVIEW
  • 6.2 INFLAMMATORY ACNE
  • 6.3 NON-INFLAMMATORY ACNE

7 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE

  • 7.1 OVERVIEW
  • 7.2 MEDICATED
  • 7.3 NON-MEDICATED
  • 7.4 MICRO-NEEDLE

8 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE

  • 8.1 OVERVIEW
  • 8.2 CHEMICAL BASED
    • 8.2.1 HYDROCOLLOID BASED
    • 8.2.2 SALICYLIC ACID BASED
    • 8.2.3 HYALURONIC ACID BASED
  • 8.3 HERBAL BASED

9 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL

  • 9.1 OVERVIEW
  • 9.2 RETAIL STORES
  • 9.3 PHARMACIES & DRUG STORES
  • 9.4 E-COMMERCE PLATFORM

10 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY COUNTRY

  • 10.1 OVERVIEW
    • 10.1.1 GERMANY
    • 10.1.2 FRANCE
    • 10.1.3 UK
    • 10.1.4 ITALY
    • 10.1.5 SPAIN
    • 10.1.6 REST OF EUROPE

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 COMPETITIVE BENCHMARKING
  • 11.3 MAJOR GROWTH STRATEGY IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET
  • 11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET
  • 11.5 KEY DEVELOPMENT ANALYSIS
  • 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.6.1 PRODUCT APPROVAL AND PRODUCT LAUNCHES
    • 11.6.2 ACQUISITION
  • 11.7 FINANCIAL MATRIX
    • 11.7.1 SALES (USD MILLION), 2021
    • 11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

12 COMPANY PROFILES

  • 12.1 3M
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS OFFERED
    • 12.1.4 KEY DEVELOPMENTS
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 KEY STRATEGIES
  • 12.2 ECOFEMINII LTD.
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS OFFERED
    • 12.2.4 KEY DEVELOPMENTS
    • 12.2.5 KEY STRATEGIES
  • 12.3 AVALON NATURAL PRODUCTS, INC.
    • 12.3.1 COMPANY OVERVIEWS
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCTS OFFERED
    • 12.3.4 KEY DEVELOPMENTS
    • 12.3.5 SWOT ANALYSIS
    • 12.3.6 KEY STRATEGIES
  • 12.4 ZITSTICKA
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS OFFERED
    • 12.4.4 KEY DEVELOPMENTS
    • 12.4.5 KEY STRATEGIES
  • 12.5 MARIO BADESCU SKIN CARE, INC.
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS OFFERED
    • 12.5.4 KEY DEVELOPMENTS
    • 12.5.5 KEY STRATEGIES
  • 12.6 CHURCH & DWIGHT CO., INC
    • 12.6.1 COMPANY OVERVIEWS
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS OFFERED
    • 12.6.4 KEY DEVELOPMENTS
    • 12.6.5 SWOT ANALYSIS
    • 12.6.6 KEY STRATEGIES
  • 12.7 STARFACE
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS OFFERED
    • 12.7.4 STARFACE: KEY DEVELOPMENTS
    • 12.7.5 SWOT ANALYSIS
    • 12.7.6 KEY STRATEGIES
  • 12.8 PEACE OUT, LLC
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS OFFERED
    • 12.8.4 KEY DEVELOPMENTS
    • 12.8.5 SWOT ANALYSIS
    • 12.8.6 KEY STRATEGIES
  • 12.9 COSRX
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS OFFERED
    • 12.9.4 KEY DEVELOPMENTS
    • 12.9.5 KEY STRATEGIES
  • 12.10 PEACH & LILLY
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 PRODUCTS OFFERED
    • 12.10.4 KEY DEVELOPMENTS
    • 12.10.5 KEY STRATEGIES

13 APPENDIX

  • 13.1 REFERENCES
    • 13.1.1 EUROPEAN SOCIETY FOR DERMATOLOGY AND PSYCHIATRY
    • 13.1.2 EUROPEAN DERMATOLOGY FORUM
    • 13.1.3 THE EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH (ESDR)
    • 13.1.4 EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    • 13.1.5 EUROPEAN SOCIETY FOR COSMETIC AND AESTHETIC DERMATOLOGY
    • 13.1.6 BRITISH ASSOCIATION OF DERMATOLOGISTS
    • 13.1.7 FRENCH SOCIETY OF DERMATOLOGY
    • 13.1.8 THE ITALIAN SOCIETY OF DERMATOLOGY
    • 13.1.9 SPANISH ASSOCIATION OF DERMATOLOGY AND VENEREOLOGY
    • 13.1.10 BRITISH ASSOCIATION OF DERMATOLOGISTS
  • 13.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 15
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18
  • TABLE 3 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR BY ACNE TYPE, 2018-2030 (USD MILLION) 34
  • TABLE 4 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR INFLAMMATORY ACNE, BY COUNTRY, 2018-2030 (USD MILLION) 34
  • TABLE 5 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR NON-INFAMMATORY ACNE, BY COUNTRY, 2018-2030 (USD MILLION) 35
  • TABLE 6 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR BY PATCH TYPE, 2018-2030 (USD MILLION) 37
  • TABLE 7 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR MEDICATED, BY COUNTRY, 2018-2030 (USD MILLION) 37
  • TABLE 8 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR NON-MEDICATED, BY COUNTRY, 2018-2030 (USD MILLION) 38
  • TABLE 9 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR MICRO-NEEDLE, BY COUNTRY, 2018-2030 (USD MILLION) 38
  • TABLE 10 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR BY INGREDIENT TYPE, 2018-2030 (USD MILLION) 40
  • TABLE 11 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY COUNTRY, 2018-2030 (USD MILLION) 40
  • TABLE 12 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018-2030 (USD MILLION) 40
  • TABLE 13 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR HYDROCOLLOID BASED, BY COUNTRY, 2018-2030 (USD MILLION) 41
  • TABLE 14 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR SALICYLIC ACID BASED, BY COUNTRY, 2018-2030 (USD MILLION) 42
  • TABLE 15 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR HYALURONIC ACID BASED, BY COUNTRY, 2018-2030 (USD MILLION) 42
  • TABLE 16 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR NON-MEDICATED, BY COUNTRY, 2018-2030 (USD MILLION) 43
  • TABLE 17 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION) 45
  • TABLE 18 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR RETAIL STORES, BY COUNTRY, 2018-2030 (USD MILLION) 46
  • TABLE 19 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR PHARMACIES & DRUG STORES, BY COUNTRY, 2018-2030 (USD MILLION) 46
  • TABLE 20 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR E-COMMERCE PLATFORM, BY COUNTRY, 2018-2030 (USD MILLION) 47
  • TABLE 21 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY COUNTRY, 2018-2030 (USD MILLION) 49
  • TABLE 22 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018-2030 (USD MILLION) 50
  • TABLE 23 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018-2030 (USD MILLION) 50
  • TABLE 24 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018-2030 (USD MILLION) 50
  • TABLE 25 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018-2030 (USD MILLION) 51
  • TABLE 26 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION) 51
  • TABLE 27 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018-2030 (USD MILLION) 52
  • TABLE 28 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018-2030 (USD MILLION) 53
  • TABLE 29 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018-2030 (USD MILLION) 53
  • TABLE 30 GERMANY ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018-2030 (USD MILLION) 53
  • TABLE 31 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION) 54
  • TABLE 32 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018-2030 (USD MILLION) 54
  • TABLE 33 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018-2030 (USD MILLION) 54
  • TABLE 34 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018-2030 (USD MILLION) 55
  • TABLE 35 FRANCE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018-2030 (USD MILLION) 55
  • TABLE 36 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION) 56
  • TABLE 37 UK ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018-2030 (USD MILLION) 56
  • TABLE 38 UK ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018-2030 (USD MILLION) 56
  • TABLE 39 UK ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018-2030 (USD MILLION) 57
  • TABLE 40 UK ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018-2030 (USD MILLION) 57
  • TABLE 41 UK ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION) 58
  • TABLE 42 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018-2030 (USD MILLION) 58
  • TABLE 43 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018-2030 (USD MILLION) 59
  • TABLE 44 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018-2030 (USD MILLION) 59
  • TABLE 45 ITALY ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018-2030 (USD MILLION) 59
  • TABLE 46 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION) 60
  • TABLE 47 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018-2030 (USD MILLION) 61
  • TABLE 48 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018-2030 (USD MILLION) 61
  • TABLE 49 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018-2030 (USD MILLION) 61
  • TABLE 50 SPAIN ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018-2030 (USD MILLION) 62
  • TABLE 51 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION) 62
  • TABLE 52 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018-2030 (USD MILLION) 63
  • TABLE 53 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018-2030 (USD MILLION) 63
  • TABLE 54 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018-2030 (USD MILLION) 64
  • TABLE 55 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018-2030 (USD MILLION) 64
  • TABLE 56 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION) 64
  • TABLE 57 MAJOR PLAYERS IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 65
  • TABLE 58 MOST ACTIVE PLAYER IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 68
  • TABLE 59 PRODUCT APPROVAL AND PRODUCT LAUNCHES 69
  • TABLE 60 ACQUISITION 69
  • TABLE 61 3M: PRODUCTS OFFERED 72
  • TABLE 62 ECOFEMINII LTD.: PRODUCTS OFFERED 74
  • TABLE 63 AVALON NATURAL PRODUCTS, INC.: PRODUCTS OFFERED 75
  • TABLE 64 ZITSTICKA: PRODUCTS OFFERED 77
  • TABLE 65 ZITSTICKA: KEY DEVELOPMENTS 77
  • TABLE 66 MARIO BADESCU SKIN CARE, INC.: PRODUCTS OFFERED 79
  • TABLE 67 CHURCH & DWIGHT CO., INC.: PRODUCTS OFFERED 81
  • TABLE 68 CHURCH & DWIGHT CO., INC: KEY DEVELOPMENTS 81
  • TABLE 69 STARFACE: PRODUCTS OFFERED 83
  • TABLE 70 PEACE OUT LLC: PRODUCTS OFFERED 85
  • TABLE 71 COSRX: PRODUCTS OFFERED 87
  • TABLE 72 PEACH & LILLY: PRODUCTS OFFERED 88  

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 12
  • FIGURE 2 EUROPE ANTI-ACNE DERMAL PATCH MARKET 14
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 21
  • FIGURE 4 MARKET DYNAMICS: EUROPE ANTI-ACNE DERMAL PATCH MARKET 24
  • FIGURE 5 DRIVER IMPACT ANALYSIS 26
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS 26
  • FIGURE 7 VALUE CHAIN: EUROPE ANTI-ACNE DERMAL PATCH MARKET 28
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: EUROPE ANTI-ACNE DERMAL PATCH MARKET 30
  • FIGURE 9 EUROPE ANTI-ACNE DERMAL PATCH MARKET, ACNE TYPE SEGMENT ATTRACTIVENESS, (USD MILLION) 33
  • FIGURE 10 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2021 & 2030 (USD MILLION) 33
  • FIGURE 11 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2021 (%) 34
  • FIGURE 12 EUROPE ANTI-ACNE DERMAL PATCH MARKET, PATCH TYPE SEGMENT ATTRACTIVENESS, (USD MILLION) 36
  • FIGURE 13 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2021 & 2030 (USD MILLION) 36
  • FIGURE 14 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2021 (%) 37
  • FIGURE 15 EUROPE ANTI-ACNE DERMAL PATCH MARKET, INGREDIENT TYPE SEGMENT ATTRACTIVENESS, (USD MILLION) 39
  • FIGURE 16 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2021 & 2030 (USD MILLION) 39
  • FIGURE 17 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2021 (%) 40
  • FIGURE 18 EUROPE ANTI-ACNE DERMAL PATCH MARKET, DISTRIBUTION CHANNEL SEGMENT ATTRACTIVENESS, (USD MILLION) 44
  • FIGURE 19 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021 & 2030 (USD MILLION) 45
  • FIGURE 20 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021 (%) 45
  • FIGURE 21 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY COUNTRY, 2021 & 2030 48
  • FIGURE 22 EUROPE ANTI-ACNE DERMAL PATCH MARKET SHARE (%), BY COUNTRY, 2021 49
  • FIGURE 23 GERMANY MARKET ANALYSIS: ANTI-ACNE DERMAL PATCH MARKET, 2018-2030 (USD MILLION) 52
  • FIGURE 24 FRANCE MARKET ANALYSIS: ANTI-ACNE DERMAL PATCH MARKET, 2018-2030 (USD MILLION) 54
  • FIGURE 25 UK MARKET ANALYSIS: ANTI-ACNE DERMAL PATCH MARKET, 2018-2030 (USD MILLION) 56
  • FIGURE 26 ITALY MARKET ANALYSIS: ANTI-ACNE DERMAL PATCH MARKET, 2018-2030 (USD MILLION) 58
  • FIGURE 27 SPAIN MARKET ANALYSIS: ANTI-ACNE DERMAL PATCH MARKET, 2018-2030 (USD MILLION) 60
  • FIGURE 28 REST OF EUROPE MARKET ANALYSIS: ANTI-ACNE DERMAL PATCH MARKET, 2018-2030 (USD MILLION) 63
  • FIGURE 29 BENCHMARKING OF MAJOR COMPETITORS 66
  • FIGURE 30 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 67
  • FIGURE 31 EUROPE ANTI-ACNE DERMAL PATCH MARKET: COMPETITIVE LANDSCAPE 68
  • FIGURE 32 SALES 2021 69
  • FIGURE 33 RESEARCH & DEVELOPMENT EXPENDITURE, 2021 70
  • FIGURE 34 3M: FINANCIAL OVERVIEW SNAPSHOT 72
  • FIGURE 35 3M: SWOT ANALYSIS 73
  • FIGURE 36 AVALON NATURAL PRODUCTS, INC.: SWOT ANALYSIS 76
  • FIGURE 37 CHURCH & DWIGHT CO., INC.: FINANCIAL OVERVIEW SNAPSHOT 80
  • FIGURE 38 CHURCH & DWIGHT CO., INC: SWOT ANALYSIS 81
  • FIGURE 39 STARFACE: SWOT ANALYSIS 84
  • FIGURE 40 PEACE OUT LLC: SWOT ANALYSIS 86
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!